Donavan T. Cheng

8.8k total citations
29 papers, 1.2k citations indexed

About

Donavan T. Cheng is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Donavan T. Cheng has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 11 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Donavan T. Cheng's work include Cancer Genomics and Diagnostics (11 papers), Colorectal Cancer Treatments and Studies (3 papers) and Melanoma and MAPK Pathways (3 papers). Donavan T. Cheng is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Colorectal Cancer Treatments and Studies (3 papers) and Melanoma and MAPK Pathways (3 papers). Donavan T. Cheng collaborates with scholars based in United States, Switzerland and China. Donavan T. Cheng's co-authors include Michael F. Berger, Palanikumar Ravindran, Hans Bitter, Marc Ladanyi, Britta Weigelt, Maria E. Arcila, David B. Solit, David M. Hyman, José Baselga and Ahmet Zehir and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Hepatology.

In The Last Decade

Donavan T. Cheng

28 papers receiving 1.2k citations

Peers

Donavan T. Cheng
Nicole Massoll United States
Johanna Strehl Germany
Ivar Skaland Norway
Serge Smeets Netherlands
Einar Gudlaugsson Norway
Donna Coffey United States
Kristen A. Atkins United States
Darren Ennis United Kingdom
Jean‐Pascal Machiels Belgium
Nicole Massoll United States
Donavan T. Cheng
Citations per year, relative to Donavan T. Cheng Donavan T. Cheng (= 1×) peers Nicole Massoll

Countries citing papers authored by Donavan T. Cheng

Since Specialization
Citations

This map shows the geographic impact of Donavan T. Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donavan T. Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donavan T. Cheng more than expected).

Fields of papers citing papers by Donavan T. Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donavan T. Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donavan T. Cheng. The network helps show where Donavan T. Cheng may publish in the future.

Co-authorship network of co-authors of Donavan T. Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Donavan T. Cheng. A scholar is included among the top collaborators of Donavan T. Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donavan T. Cheng. Donavan T. Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Biao, HebatAllah Kasem El‐Senousey, Meng Zhou, et al.. (2021). Deletion in KRT75L4 linked to frizzle feather in Xiushui Yellow Chickens. Animal Genetics. 53(1). 101–107. 5 indexed citations
2.
Murali, Rajmohan, Pier Selenica, David N. Brown, et al.. (2018). Somatic genetic alterations in synchronous and metachronous low‐grade serous tumours and high‐grade carcinomas of the adnexa. Histopathology. 74(4). 638–650. 20 indexed citations
3.
Cheng, Donavan T., Meera Prasad, Yvonne Chekaluk, et al.. (2017). Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing. BMC Medical Genomics. 10(1). 33–33. 75 indexed citations
4.
Sirintrapun, S. Joseph, Ahmet Zehir, Aijazuddin Syed, et al.. (2016). Translational Bioinformatics and Clinical Research (Biomedical) Informatics. Clinics in Laboratory Medicine. 36(1). 153–181. 5 indexed citations
5.
Ross, Dara S., Ahmet Zehir, Donavan T. Cheng, et al.. (2016). Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status. Journal of Molecular Diagnostics. 19(2). 244–254. 91 indexed citations
6.
Sirintrapun, S. Joseph, Ahmet Zehir, Aijazuddin Syed, et al.. (2015). Translational Bioinformatics and Clinical Research (Biomedical) Informatics. Surgical pathology clinics. 8(2). 269–288. 5 indexed citations
7.
Schrader, Kasmintan A., Donavan T. Cheng, Joseph Vijai, et al.. (2015). Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases.. Journal of Clinical Oncology. 33(15_suppl). 1509–1509. 3 indexed citations
8.
Harding, James J., Federica Catalanotti, Rodrigo Ramella Munhoz, et al.. (2015). A Retrospective Evaluation of Vemurafenib as Treatment for BRAF-Mutant Melanoma Brain Metastases. The Oncologist. 20(7). 789–797. 50 indexed citations
9.
Hyman, David M., David B. Solit, Maria E. Arcila, et al.. (2015). Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trials. Drug Discovery Today. 20(12). 1422–1428. 103 indexed citations
10.
11.
Abdel‐Wahab, Omar, Virginia M. Klimek, Agnès Viale, et al.. (2014). Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies. Cancer Discovery. 4(5). 538–545. 59 indexed citations
12.
Cheng, Donavan T., Janice Cheng, Talia Mitchell, et al.. (2014). Detection of Mutations in Myeloid Malignancies through Paired-Sample Analysis of Microdroplet-PCR Deep Sequencing Data. Journal of Molecular Diagnostics. 16(5). 504–518. 17 indexed citations
13.
Bauer, Carla M. T., Donavan T. Cheng, John Allard, et al.. (2013). Precision cut lung slices: A novel method for examining mechanisms underlying respiratory diseases. European Respiratory Journal. 42(Suppl 57). P669–P669. 1 indexed citations
14.
Cheng, Donavan T., X. Cynthia, Jens Niewoehner, et al.. (2013). Thymic stromal lymphopoietin receptor blockade reduces allergic inflammation in a cynomolgus monkey model of asthma. Journal of Allergy and Clinical Immunology. 132(2). 455–462. 42 indexed citations
15.
Cockayne, Debra A., Donavan T. Cheng, Benjamin Waschki, et al.. (2012). Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity. PLoS ONE. 7(6). e38629–e38629. 75 indexed citations
16.
Fletcher, Simon P., Daniel J. Chin, Yongmei Ji, et al.. (2012). Transcriptomic analysis of the woodchuck model of chronic hepatitis B. Hepatology. 56(3). 820–830. 78 indexed citations
17.
Allantaz, Florence, Donavan T. Cheng, Tobias Bergauer, et al.. (2012). Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression. PLoS ONE. 7(1). e29979–e29979. 169 indexed citations
18.
Fletcher, Simon P., Daniel J. Chin, Donavan T. Cheng, et al.. (2012). Identification of an intrahepatic transcriptional signature associated with self-limiting infection in the woodchuck model of hepatitis B. Hepatology. 57(1). 13–22. 39 indexed citations
19.
Viswanathan, Sowmya, et al.. (2005). Clonal evolution of stem and differentiated cells can be predicted by integrating cell‐intrinsic and ‐extrinsic parameters. Biotechnology and Applied Biochemistry. 42(2). 119–131. 15 indexed citations
20.
Cheng, Donavan T., et al.. (1995). Successful Treatment of Metastatic Small Cell Carcinoma of the Bladder With Methotrexate, Vinblastine, Doxorubicin and Cisplatin Therapy. The Journal of Urology. 153(2). 417–419. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicole Massoll Breakdown of academic impact, for papers by Johanna Strehl Breakdown of academic impact, for papers by Ivar Skaland Breakdown of academic impact, for papers by Serge Smeets Breakdown of academic impact, for papers by Einar Gudlaugsson Breakdown of academic impact, for papers by Donna Coffey Breakdown of academic impact, for papers by Kristen A. Atkins Breakdown of academic impact, for papers by Darren Ennis Breakdown of academic impact, for papers by Jean‐Pascal Machiels
Rankless by CCL
2026